|
|
| 华熙生物科技有限公司, 00963.HK - 综合损益表 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
2011-12 |
2010-12 |
2009-12 |
2008-12 |
2007-12 |
2006-12 |
2005-12 |
| 营业额 |
844,388 |
650,868 |
481,301 |
375,180 |
274,966 |
206,064 |
153,661 |
117,190 |
116,599 |
91,081 |
84,585 |
87,327 |
| 经营溢利 |
313,752 |
254,627 |
207,738 |
135,742 |
120,848 |
105,907 |
85,127 |
69,091 |
65,137 |
54,366 |
49,404 |
62,425 |
| 非经营/ 特殊项目 |
0 |
0 |
0 |
0 |
0 |
0 |
-8,785 |
-8,996 |
-10,407 |
-8,832 |
0 |
0 |
| 联营公司 |
20,454 |
25 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 除税前经营溢利 |
288,823 |
237,925 |
198,121 |
125,759 |
111,781 |
96,937 |
76,342 |
60,095 |
54,730 |
45,534 |
49,404 |
62,425 |
| 税项 |
60,723 |
47,530 |
36,055 |
31,362 |
22,511 |
24,312 |
15,900 |
9,407 |
10,883 |
4,923 |
5,754 |
5,434 |
| 少数股东权益 |
-1 |
2 |
-1 |
-1 |
-2 |
-3 |
0 |
0 |
0 |
0 |
0 |
0 |
| 股东应占溢利 |
228,101 |
190,393 |
162,067 |
94,398 |
89,272 |
72,628 |
60,442 |
50,688 |
43,847 |
40,611 |
43,650 |
56,991 |
| 货币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
| 单位 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
| 主要项目 |
| 折旧 |
58,658 |
40,245 |
14,111 |
12,762 |
10,384 |
10,010 |
8,289 |
7,355 |
4,993 |
4,707 |
6 |
6 |
| 利息 |
45,383 |
16,727 |
9,617 |
9,983 |
9,067 |
8,970 |
0 |
472 |
2,171 |
927 |
0 |
0 |
| 利息拨作发展资本 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
10 |
0 |
0 |
0 |
0 |
| 处置/重估固定资产 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 税率(%) |
21.02 |
19.98 |
18.2 |
24.94 |
20.14 |
25.08 |
20.83 |
15.65 |
19.88 |
10.81 |
11.65 |
8.7 |
| 营业额增长(%) |
29.73 |
35.23 |
28.29 |
36.45 |
33.44 |
34.1 |
31.12 |
0.51 |
28.02 |
7.68 |
-3.14 |
0.0 |
| 股东应占溢利增长(%) |
19.81 |
17.48 |
71.68 |
5.74 |
22.92 |
20.16 |
19.24 |
15.6 |
7.97 |
-6.96 |
-23.41 |
|
| 核数师意见 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
说明:1代表无保留意见;2代表保留意见;3代表修改意见
|
|